Should I buy Itron, Inc. (ITRI) stock or is it too late?
⭐ The most reliable of them, either direction: Needham — 55% of its targets hit on this sector (593 calls tested). It aims for $128 (+29 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).
Firm-by-firm track record on Itron, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Roth MKM | 86 % | +22.9 % | 7 | $130 +31% |
| Canaccord Genuity | 56 % | +10.7 % | 9 | $132 +33% |
| Argus Research | 40 % | +4.0 % | 5 | $82 -17% |
| Baird | 38 % | +1.0 % | 8 | $128 +29% |
| Oppenheimer | 56 % | -2.1 % | 9 | $135 +36% |
| Piper Sandler | 67 % | -3.9 % | 6 | $121 +22% |
| Guggenheim | 20 % | -7.8 % | 5 | $155 +56% |
| JP Morgan | 25 % | -24.0 % | 8 | $113 +14% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $130, i.e. +31% from the current price ($99).
- The most reliable firm on ITRI, TD Cowen (75% hit rate, 4 scored calls), targets $130 (call made on April 29, 2026, maturing on April 29, 2027) (+31%) in its most recent call.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on ITRI
Median target $130 (+31%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Itron, Inc. now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $130 (+31%), and TD Cowen (most reliable on ITRI, 75%) targets $130. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Itron, Inc.?
Not according to analysts: the median target ($130) is still +31% above the current price ($99) (most reliable on ITRI: TD Cowen, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Itron, Inc. still worth investing in?
It depends on the gap between the price ($99) and its estimated value: analysts target $130 on median (+31%), with 100% buys (most reliable on ITRI: TD Cowen, 75%). Cross-check with their real reliability on ITRI and the cautions above. Information, not advice.
What's the main risk in buying ITRI?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Itron, Inc. profile (consensus, analyst reliability, price target, performance).